The data available to guide clinical management of acute lung injury and acute respiratory distress syndrome are much more limited for infants and children than for adult patients. This paper reviews the available medical data and the pertinent physiology on the management of pediatric patients with acute lung injury. With the collaboration of multicenter investigation networks, definitive pediatric data may be on the horizon to better guide our clinical practice.
BernardGR, ArtigasA, BrighamKL, CarletJ, FalkeK, HudsonL, et al. The North American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994; 149(3):818–824.
2.
EricksonS, SchiblerA, NumaA, NuthallG, YungM, PascoeE, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med, 2007; 8(4):317–323.
3.
ZimmermanJJ, AkhtarSR, CaldwellE, RubenfeldGD. Incidence and outcomes of pediatric acute lung injury. Pediatrics, 2009; 124(1):87–95.
4.
CheifetzIM. Management of acute lung injury: Sharing data between adults and children. Respir Care, 2011; 56(9):1258–1268; discussion 1268-1272.
5.
RandolphAG, MeertKL, O'NeilME, HansonJH, LuckettPM, ArnoldJH, et al. on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators Network. The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med, 2003; 167(10):1334–1340.
6.
RandolphAG, WypijD, VenkataramanST, HansonJH, GedeitRG, MeertKLet al; on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial. JAMA, 2002; 288(20):2561–2568.
7.
SantschiM, JouvetP, LeclercF, GauvinF, NewthCJ, CarrollCLet al; on behalf of the PALIVE Investigators; Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI) and the European Society of Pediatric and Neonatal Intensive Care (ESPNIC). Acute lung injury in children: therapeutic practice and feasibility of international clinical trials. Pediatr Crit Care Med, 2010; 11(6):681–689.
8.
TimmonsOD, HavensPL, FacklerJC. Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization. Chest, 1995; 108(3):789–797.
9.
FloriHR, GliddenEV, RutherfordGW, MatthayMA. Pediatric acute lung injury: Prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med, 2005; 171(9):995–1001.
10.
CurleyMA, HibberdPL, FinemanLD, WypijD, ShihMC, ThompsonJE, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA, 2005; 294(2):229–237.
11.
CostilJ, CloupM, LeclercF, DevictorD, BeaufilsF, SimeoniU, et al. Acute respiratory distress syndrome (ARDS) in children: Multicenter Collaborative Study of the French Group of Pediatric Intensive Care. Pediatr Pulmonol, 1995; 11(Suppl.):106–107.
12.
GohAY, ChanPW, LumLC, RoziahM. Incidence of acute respiratory distress syndrome: a comparison of two definitions. Arch Dis Child, 1998; 79(3):256–259.
KhemaniRG, PatelNR, BartRD3rd, NewthCJ. Comparison of the pulse oximetric saturation/fraction of inspired oxygen ratio and the PaO2/fraction of inspired oxygen ratio in children. Chest, 2009; 135(3):662–668.
15.
RiceTW, WheelerAP, BernardGR, HaydenDL, SchoenfeldDA, WareLB; on behalf of the National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest, 2007; 132(2):410–417.
16.
ThomasNJ, ShafferML, WillsonDF, ShihMC, CurleyMA. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med, 2010; 11(1):12–17.
17.
WillsonDF, ThomasNJ, MarkovitzBP, BaumanLA, DiCarloJV, PonSet al; on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA, 2005; 293(4):470–476.
18.
RandolphAG, ForbesPW, GedeitRG, ArnoldJH, WetzelRC, LuckettPM, et al. on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Cumulative fluid intake minus output is not associated with ventilator weaning duration or extubation outcomes in children. Pediatr Crit Care Med, 2005; 6(6):642–647.
19.
BurrJS, JenkinsTL, HarrisonR, MeertK, AnandKJ, BergerJTet al; for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). The Collaborative Pediatric Critical Care Research Network (CPCCRN) Critical Pertussis Study: collaborative research in pediatric critical care medicine. Pediatr Crit Care Med, 2011; 12(4):387–392.
20.
MeertKL, EgglyS, DeanJM, PollackM, ZimmermanJ, AnandKJ, et al. Ethical and logistical considerations of multicenter parental bereavement research. J Palliat Med, 2008; 11(3):444–450.
21.
MeertKL, EgglyS, PollackM, AnandKJ, ZimmermanJ, CarcilloJet al; on behalf of the National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Parents' perspectives regarding a physician-parent conference after their child's death in the pediatric intensive care unit. J Pediatr, 2007; 151(1):50–55, e1-e2.
22.
WillsonDF, DeanJM, NewthC, PollackM, AnandKJ, MeertKet al; on behalf of the Collaborative Pediatric Critical Care Research Network (CPCCRN). Pediatr Crit Care Med, 2006; 7(4):301–307.
23.
YungM, SlaterA, FestaM, WilliamsG, EricksonS, PettilaVet al; on behalf of the Australia and New Zealand Intensive Care Influenza Investigators and the Paediatric Study Group and the Clinical Trials Group of the Australia New Zealand Intensive Care Society. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics, 2011; 127(1):e156–e163.
24.
The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med, 2009; 361(20):1925–1934.
25.
KhemaniRG, MarkovitzBP, CurleyMAQ. Characteristics of children Intubated and mechanically ventilated in 16 PICUs. Chest, 2009; 136(3):765–771.
26.
RandolphAG. Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med, 2009; 37(8):2448–2454.
27.
KhemaniRG, NewthCJ. The design of future pediatric mechanical ventilation trials for acute lung injury. Am J Respir Crit Care Med, 2010; 182(12):1465–1474.
28.
The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1301–1308.
29.
AmatoMB, BarbasCS, MedeirosDM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med, 1998; 338(6):347–354.
30.
BrochardL, Roudot-ThoravalF, RoupieE, DelclauxC, ChastreJ, Fernandez-MondejarE, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med, 1998; 158(6):1831–1838.
31.
BrowerRG, ShanholtzCB, FesslerHE, ShadeDM, WhitePJr, WienerCM, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med, 1999; 27(8):1492–1498.
32.
EichackerPQ, GerstenbergerEP, BanksSM, CuiX, NatansonC. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med, 2002; 166(11):1510–1514.
33.
StewartTE, MeadeMO, CookDJ, GrantonJT, HodderRV, LapinskySE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med, 1998; 338(6):355–361.
34.
BrowerRG, LankenPN, MacIntyreN, MatthayMA, MorrisA, AncukiewiczMet al; on behalf of the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med, 2004; 351(4):327–336.
35.
MeadeMO, CookDJ, GuyattGH, SlutskyAS, ArabiYM, CooperDJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA, 2008; 299(6):637–645.
36.
Mercat A RichardJC, VielleB, JaberS, OsmanD, DiehlJLet al; on behalf of the Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA, 2008; 299(6):646–655.
37.
BrielM, MeadeM, MercatA, BrowerRG, TalmorD, WalterSD, et al. Higher vs. lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA, 2010; 303(9):865–873.
38.
AlbualiWH, SinghRN, FraserDD, SeabrookJA, KavanaghBP, ParshuramCS, KorneckiA. Have changes in ventilation practice improved outcome in children with acute lung injury?. Pediatr Crit Care Med, 2007; 8(4):324–330.
39.
CannonML, CornellJ, TrippDS, GentileMA, HubbleCL, MelionesJN, CheifetzIM. Tidal volumes for ventilated infants should be determined with a pneumotachometer placed at the endotracheal tube. Am J Respir Crit Care Med, 2000; 162(6):2109–2112.
40.
CastleRA, DunneCJ, MokQ, WadeAM, StocksJ. Accuracy of displayed tidal volume in the pediatric intensive care unit. Crit Care Med, 2002; 39(11):2566–2574.
41.
ChowLC, VanderhalA, RaberJ, SolaA. Are tidal volume measurements in neonatal pressure-controlled ventilation accurate?. Pediatr Pulmonol, 2002; 34(3):196–202.
42.
HeulittMJ, ThurmanTL, HoltSJ, JoCH, SimpsonP. Reliability of displayed tidal volume in infants and children during dual-controlled ventilation. Pediatr Crit Care Med, 2009; 10(6):661–667.
43.
HessDR. Approaches to conventional mechanical ventilation of the patient with acute respiratory distress syndrome. Respir Care, 2011:56(10):1555–1572.
44.
ArnoldJH, HansonJH, Toro-FigueroLO, GutiérrezJ, BerensRJ, AnglinDL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med, 1994; 22(10):1530–1539.
45.
SudS, SudM, FriedrichJO, MeadeMO, FergusonND, WunschH, AdhikariNK. High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ, 2010; 340:c2327. DOI: 10.1136/bmj.c2327.
46.
TenIS, AndersonMR. Is high-frequency ventilation more beneficial than low-tidal volume conventional ventilation?. Respir Care Clin N Am, 2006; 12(3):437–451.
47.
VentreKM, ArnoldJH. High frequency oscillatory ventilation in acute respiratory failure. Paediatr Respir Rev, 2004; 5(4):323–332.
48.
ArnoldJH, AnasNG, LuckettP, CheifetzIM, ReyesG, NewthCJ, et al. High-frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med, 2000; 28(12):3913–3919.
49.
JobeAH. Pulmonary surfactant therapy. N Engl J Med, 1993; 328(12):861–868.
50.
SollRF. Surfactant therapy in the USA: trials and current routines. Biol Neonate, 1997; 71(Suppl 1):1–7.
LotzeA, KnightGR, MartinGR, BulasDI, HullWM, O'DonnellRM, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr, 1993; 122(2):261–268.
53.
LotzeA, MitchellBR, BulasDI, ZolaEM, ShalwitzRA, GunkelJH. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr, 1998; 132(1):40–47.
54.
WillsonDF, ChessPR, NotterRH. Surfactant for pediatric acute lung injury. Pediatr Clin North Am, 2008; 55(3):545–575.
55.
WillsonDF, ZaritskyA, BaumanLA, DockeryK, JamesRL, ConradD, et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med, 1999; 27(1):188–195.
56.
WillsonDF, JiaoJH, BaumanLA, ZaritskyA, CraftH, DockeryK, et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med, 1996; 24(8):1316–1322.
57.
CzajaAS. A critical appraisal of a randomized controlled trial: Willson et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476). Pediatr Crit Care Med, 2007; 8(1):50–53.
58.
KeseciogluJ, BealeR, StewartTE, FindlayGP, RoubyJJ, HolzapfelL, et al. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med, 2009; 180(10):989–994.
59.
WillsonDF, NotterRH. The future of exogenous surfactant therapy. Respir Care, 2011; 56(9):1369–1386; discussion 1386-1388.
60.
GerlachH, KehD, SemmerowA, BuschT, LewandowskiK, PappertDM, et al. Dose response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med, 2003; 167(7):1008–1015.
61.
DellingerRP, ZimmermanJL, TaylorRW, StraubeRC, HauserDL, CrinerGJ, et al. on behalf of the Inhaled Nitric Oxide in ARDS Study Group. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med, 1998; 26(1):15–23.
62.
TaylorRW, ZimmermanJL, DellingerRP, StraubeRC, CrinerGJ, DavisKJr, et al. on behalf of the Inhaled Nitric Oxide in ARDS Study Group. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA, 2004; 291(13):1603–1609.
63.
AdhikariNK, BurnsKE, FriedrichJO, GrantonJT, CookDJ, MeadeMO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ, 2007; 334(7597):779.
64.
AfshariA, BrokJ, MøllerAM, WetterslevJ. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with Meta-analysis and trial sequential analysis. Anesth Analg, 2011; 11(6):1411–1421.
65.
AfshariA, BrokJ, MollerAM, WetterslevJ. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev, 2010;(7):CD002787.
66.
DahlemP, van AalderenWMC, de NeefM, DijkgraafMGW, BosAP. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med, 2004; 32(4):1055–1060.
67.
WiedemannHP, WheelerAP, BernardGR, ThompsonBT, HaydenD, de BoisblancBet al; on behalf of the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid management strategies in acute lung injury. N Engl J Med, 2006; 354(24):2564–2575.
68.
OgnibeneKL, VawdreyDK, BiagasKV. The association of age, illness severity, and glycemic status in a pediatric intensive care unit. Pediatr Crit Care Med, 2011 [Epub ahead of print].
69.
MeyfroidtG, IngelsC, Van den BergheG. Glycemic control in the ICU. N Engl J Med, 2011; 364(13):1280–1281.
70.
VlasselaersD, MilantsI, DesmetL, WoutersPJ, VanhorebeekI, van den HeuvelI, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet, 2009; 373(9663):547–556.
71.
Van den BergheG. First do no harm. hypoglycemia or hyperglycemia?. Crit Care Med, 2006; 34(11):2843–2844.
72.
KavanaghBP, McCowenKC. Clinical practice. Glycemic control in the ICU. N Engl J Med, 2010; 363(26):2540–2546.
73.
LacroixJ, HébertPC, HutchisonJS, HumeHA, TucciM, DucruetTet al; on behalf of the TRIPICU Investigators, the Canadian Critical Care Trials Group, and the Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med, 2007; 356(16):1609–1619.
74.
AbdelsalamM, CheifetzIM. Goal-directed therapy for severely hypoxemic patients with acute respiratory distress syndrome: permissive hypoxemia. Respir Care, 2010; 55(11):1483–1490.
75.
Extracorporeal Life Support Organization (ELSO) Database. January, 2011.
76.
The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA, 2009; 302(17):1888–1895.
77.
TurnerDA, RehderKJ, Peterson-CarmichaelSL, OzmentCP, Al-HegelanMS, WillifordWL, et al. Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. Respir Care, 2011; 56(7):941–946.
78.
TurnerDA, PetersMA, WillifordWL, ThalmanJJ, ShearerIR, WalczakRJ, et al. Development of a collaborative program to provide extracorporeal membrane oxygenation for adult refractory hypoxemia within the framework of a pandemic. Pediatr Crit Care Med, 2011; 12(4):426–430.
79.
DaltonHJ. Extracorporeal life support: moving at the speed of light. Respir Care, 2011; 56(9):1445–1453; discussion 1454-1456.
80.
TurnerDA, CheifetzIM, RehderKJ, WillifordWL, BanuelosSJ, LinSS, DavidRD, ZaasD. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med, 2011; in press.
81.
ZabrockiLA, BroganTV, StatlerKD, PossWB, RollinsMD, BrattonSL. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med, 2011; 39(2):364–370.
82.
IjlandMM, HeunksLM, van der HoevenJG. Bench-to-bedside review: hypercapnic acidosis in lung injury: from permissive to therapeutic. Crit Care, 2010; 14(6):237.
83.
PeltekovaV, EngelbertsD, OtulakowskiG, UematsuS, PostM, KavanaghBP. Hypercapnic acidosis in ventilator-induced lung injury. Intensive Care Med, 2010; 36(5):869–878.
84.
MasoodA, YiM, LauM, BelcastroR, ShekS, PanJ, et al. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am J Physiol Lung Cell Mol Physiol, 2009; 297(5):L920–L930.
85.
HassettP, LaffeyJG. Permissive hypercapnia: balancing risks and benefits in the peripheral microcirculation. Crit Care Med, 2007; 35(9):2229–2231.
86.
CheifetzIM, HamelDS. Is permissive hypoxemia a beneficial strategy for pediatric acute lung injury?. Respir Care Clin N Am, 2006; 12(3):359–369.
